Sophie Testa to Coronavirus Infections
This is a "connection" page, showing publications Sophie Testa has written about Coronavirus Infections.
Connection Strength
0.126
-
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study. Intern Emerg Med. 2020 Nov; 15(8):1425-1433.
Score: 0.028
-
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience. J Thromb Haemost. 2020 06; 18(6):1320-1323.
Score: 0.028
-
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients. Intern Emerg Med. 2020 08; 15(5):751-753.
Score: 0.027
-
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?] Ann Biol Clin (Paris). 2020 10 01; 78(5):471-481.
Score: 0.007
-
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring. Crit Care. 2020 06 19; 24(1):364.
Score: 0.007
-
Lights and shadows of SARS-CoV-2 infection risk assessment in endoscopy. Dig Liver Dis. 2020 08; 52(8):816-818.
Score: 0.007
-
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases. Intern Emerg Med. 2020 Aug; 15(5):783-786.
Score: 0.007
-
Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? Eur J Intern Med. 2020 07; 77:147-149.
Score: 0.007
-
COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence. Blood Transfus. 2020 05; 18(3):226-229.
Score: 0.007
-
SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic. Dig Liver Dis. 2020 07; 52(7):700-701.
Score: 0.002